Table 1.
NBS Protein Expression (Nuclear) | p-Value | ||
Low | High | 0.0001 | |
Sensitive | 131 (74.9%) | 44 (25.1%) | |
Resistant * | 5 (31.3%) | 11 (68.8%) | |
NBS Protein Expression (Cytoplasmic) | p-Value | ||
Low | High | 0.676 | |
Sensitive | 97 (55.4%) | 78 (44.6%) | |
Resistant * | 8 (50%) | 8 (50%) |
* = Platinum resistance was defined as patients who had progression during first-line platinum chemotherapy or relapse within 6 months after completion of chemotherapy.